SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-043246
Filing Date
2020-07-21
Accepted
2020-07-21 19:33:49
Documents
2
Period of Report
2020-07-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2174
2 POA DOCUMENT poa.txt EX-24.3_929719 2646
  Complete submission text file 0001209191-20-043246.txt   6228
Mailing Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Issuer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CASCADIAN THERAPEUTICS, INC. 3101 WESTERN AVE., SUITE 600 SEATTLE WA 98121
Business Address
EASTLAND JULIA MARIE (Reporting) CIK: 0001500189 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34207 | Film No.: 201039937